Cargando…
Given the complexity of the human genome, can 'personalised medicine' or 'individualised drug therapy' ever be achieved?
Autor principal: | Nebert, Daniel W |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3525196/ https://www.ncbi.nlm.nih.gov/pubmed/19706359 http://dx.doi.org/10.1186/1479-7364-3-4-299 |
Ejemplares similares
-
Personalised medicine in paediatrics: individualising treatment in children with rare neurological diseases
por: Scarpa, Maurizio, et al.
Publicado: (2011) -
Personalised medicine: are we ready?
por: Louis, Renaud, et al.
Publicado: (2017) -
Breast cancer genome heterogeneity: a challenge to personalised medicine?
por: Swanton, Charles, et al.
Publicado: (2011) -
Individualised patient profile: clinical utility of Flammer syndrome phenotype and general lessons for predictive, preventive and personalised medicine
por: Golubnitschaja, Olga, et al.
Publicado: (2018) -
Personalised versus non-individualised case-based CME: A randomised pilot study
por: Stoevelaar, Herman, et al.
Publicado: (2022)